US BANCORP \DE\ - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 78 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2013. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q1 2022$9,000
-10.0%
13,969
+47.3%
0.00%
Q4 2021$10,000
+42.9%
9,486
+146.6%
0.00%
Q3 2021$7,000
+75.0%
3,846
+160.6%
0.00%
Q2 2021$4,0001,476
+4512.5%
0.00%
Q1 2021$0
-100.0%
32
-93.6%
0.00%
Q2 2020$2,000
+100.0%
5000.0%0.00%
Q1 2020$1,000
-50.0%
5000.0%0.00%
Q4 2019$2,0000.0%5000.0%0.00%
Q3 2019$2,000
-33.3%
5000.0%0.00%
Q2 2019$3,000
-91.4%
500
-95.5%
0.00%
Q3 2018$35,000
+6.1%
11,0000.0%0.00%
Q2 2018$33,000
-23.3%
11,0000.0%0.00%
Q1 2018$43,000
-6.5%
11,0000.0%0.00%
Q4 2017$46,000
-32.4%
11,0000.0%0.00%
Q3 2017$68,0000.0%11,0000.0%0.00%
Q2 2017$68,000
-2.9%
11,0000.0%0.00%
Q1 2017$70,000
+18.6%
11,0000.0%0.00%
Q4 2016$59,000
-4.8%
11,0000.0%0.00%
Q3 2016$62,000
+3.3%
11,0000.0%0.00%
Q2 2016$60,000
-26.8%
11,0000.0%0.00%
Q1 2016$82,000
-9.9%
11,0000.0%0.00%
Q4 2015$91,000
-8.1%
11,0000.0%0.00%
Q3 2015$99,000
-25.0%
11,0000.0%0.00%
-100.0%
Q2 2015$132,000
+11.9%
11,0000.0%0.00%
Q1 2015$118,000
+110.7%
11,0000.0%0.00%
Q4 2014$56,000
+93.1%
11,0000.0%0.00%
Q3 2014$29,000
-34.1%
11,0000.0%0.00%
Q2 2014$44,000
-12.0%
11,0000.0%0.00%
Q1 2014$50,000
+4.2%
11,0000.0%0.00%
Q4 2013$48,000
+11.6%
11,0000.0%0.00%
Q3 2013$43,000
+87.0%
11,0000.0%0.00%
Q2 2013$23,00011,0000.00%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q4 2013
NameSharesValueWeighting ↓
Third Security, LLC 9,709,607$51,946,0002.80%
MILLER VALUE PARTNERS, LLC 4,900,721$26,219,0001.15%
MSD Partners, L.P. 3,410,500$18,246,0000.92%
Michael & Susan Dell Foundation 66,749$357,0000.26%
Glacier Peak Capital LLC 68,043$364,0000.21%
Vident Investment Advisory, LLC 114,980$615,0000.08%
SFMG, LLC 62,433$334,0000.07%
Virtus ETF Advisers LLC 40,359$216,0000.06%
Steward Partners Investment Advisory, LLC 23,187$124,0000.06%
O'Dell Group, LLC 10,142$54,0000.05%
View complete list of ZIOPHARM ONCOLOGY INC shareholders